The study found that fasting did not protect people from contracting COVID-19, but it apparently lessened the severity of the symptoms for those who did fall ill.
Intermountain Healthcare reports that many who intermittently fast have been inadvertently protecting themselves.
“People who report in these studies that they fast routinely ... tend to be members of The Church of Jesus Christ of Latter-day Saints,” said Dr. Benjamin Horne, director of cardiovascular and genetic epidemiology at Intermountain Healthcare. Of those people, 205 tested positive for the coronavirus between March 2020 and February 2021, before vaccines were widely available. And 73 said they regularly fasted at least once a month.in “BMJ Nutrition, Prevention & Health,” relies on the fact that “a large proportion of the population in the Intermountain West fasts on a routine basis — primarily, but not exclusively, for religious purposes,” Horne said.
Horne said intermittent fasting activates several “biological mechanisms” that reduce the severity of COVID-19 symptoms — mechanisms related to inflammation, turning off and activating immune cells, and preventing COVID-19 from being able to infect other cells.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Utah study: Intermittent fasting can lower your risk of dying from COVID-19Utahns who practice intermittent fasting have potentially been unknowingly lowering their risk of suffering severe effects from COVID-19 infection. That’s the conclusion of a study by doctors at Intermountain Healthcare.
Read more »
COVID-19 third leading cause of death in 2021, study saysResearchers looked at death certificates from the Centers for Disease Control and Prevention to gather the information.
Read more »
What to Know About Vaccinating Your Young Child Against COVID-195 good reasons to vaccinate your kid, according to the latest data
Read more »
Curevac sues BioNTech over COVID-19 vaccine's mRNA technologyCureVac is suing Pfizer's German partner BioNTech for alleged patent infringement related to the development of their mRNA vaccines against COVID-19.
Read more »